Suppr超能文献

印度特发性炎性肌病患者感染负担高:MyoCite 数据集观察结果的验证。

High burden of infections in Indian patients with Idiopathic Inflammatory Myopathy: validation of observations from the MyoCite dataset.

机构信息

Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.

出版信息

Rheumatology (Oxford). 2021 Sep 1;60(9):4315-4326. doi: 10.1093/rheumatology/keab015.

Abstract

OBJECTIVE

To determine the prevalence, profile and predictors of infections in an Indian cohort with idiopathic inflammatory myopathies (IIM).

METHODS

We reviewed the records of a retrospective cohort with IIM enrolled from consecutive patients being followed up in the clinic, and these constituted the observation cohort. A newly diagnosed inception cohort with IIM were followed prospectively as the validation cohort for confirmation of observations and comparison with the observation cohort.

RESULTS

Among the 68 patients in the observation cohort (average age 33.4 years, female:male 4.2:1), 37 (54.4%) experienced 54 infections between them; of these 54 infections, 21 (38.8%) were major and recurrent infections and they occurred in 11 patients (16.17%) over 3.08 years. Tuberculosis was the most common infection (12, 22.2%), with a predominance of extrapulmonary forms. Serum protein [odds ratio (OR) 0.44], platelets (0.44) at disease onset and daily steroid dose (1.04) predicted major infections on multivariate analysis. A higher daily dose of steroids at first infection correlated with number of recurrent infections. The infection-free 1-year survival was 73.8%.Of the 70 patients in the validation cohort (average age 35.7 years, female:male 3.7:1), 3 had myositis attributed to an infection. A similar proportion of the cohort experienced infections (22, 33.3%) with similar number of major (10, 45.4%) and recurrent (4, 18%) infections being recorded. The most common infection was community-acquired pneumonia, followed by tuberculosis, with serum albumin (OR 0.25) at disease onset being the only predictor. The one-year infection-free survival rate was 64.7%. Those who had a major infection had increased mortality at 1 year, with a survival rate of 60%, compared with 89.09% in those without.In both cohorts, a daily prednisone dose >6.25 mg predisposed to major infections.

CONCLUSION

Major and recurrent infections are common in Indian IIM patients and confer higher risk for future infections and lower survival. Respiratory and atypical bacterial infections such as tuberculosis occur throughout the disease course.

摘要

目的

确定印度特发性炎性肌病(IIM)患者感染的流行率、特征和预测因素。

方法

我们回顾了从连续就诊的诊所患者中招募的回顾性队列的记录,这些患者构成了观察队列。新诊断的特发性炎性肌病患者前瞻性入组作为验证队列,以确认观察结果并与观察队列进行比较。

结果

在观察队列的 68 名患者中(平均年龄 33.4 岁,男女比例为 4.2:1),有 37 名(54.4%)患者发生了 54 次感染;其中 21 次(38.8%)为重大且复发性感染,发生在 11 名(16.17%)患者中,历时 3.08 年。结核病是最常见的感染(12 例,22.2%),以肺外形式为主。多变量分析显示,发病时血清蛋白(比值比[OR]0.44)、血小板(OR0.44)和每日类固醇剂量(OR1.04)预测重大感染。首次感染时的较高每日类固醇剂量与复发性感染次数相关。无感染的 1 年生存率为 73.8%。验证队列中有 70 名患者(平均年龄 35.7 岁,男女比例为 3.7:1),其中 3 名患者的肌炎归因于感染。该队列的感染比例相似(22 例,33.3%),重大感染(10 例,45.4%)和复发性感染(4 例,18%)的数量相似。最常见的感染是社区获得性肺炎,其次是结核病,发病时血清白蛋白(OR0.25)是唯一的预测因素。1 年无感染生存率为 64.7%。发生重大感染的患者在 1 年内死亡率更高,生存率为 60%,而无重大感染的患者生存率为 89.09%。在两个队列中,每日泼尼松剂量>6.25mg 易发生重大感染。

结论

印度特发性炎性肌病患者常发生重大和复发性感染,这增加了未来感染和降低了生存率的风险。呼吸道和非典型细菌感染,如结核病,在整个疾病过程中都有发生。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验